Impact 2021

A Year in Biomedical Commercialization at the University of Michigan

2021 FFMI Impact Report

Fast Forward Medical Innovation (FFMI) offers funding, education, and business development resources to help biomedical researchers navigate the road to successful innovation and commercialization.

From entrepreneurial organizations on campus to partners in Michigan and across the globe, we are creating an environment and culture that nurtures technologies and supports life sciences. The ultimate goal of our research is for it to impact patients and their families.

We invite you click on the image to the left to view our latest annual report. Below are metrics that provide a snapshot of biomedical commercialization activities for the U-M Medical School’s fiscal year 2021.

Interested in a broader view of research at the University of Michigan Medical School? CLICK HERE to view the 2021 U-M Medical School Office of Research Annual Report.

INDUSTRY PARTNERSHIPS

205

Invention Reports

2020: 241
2019: 226
2018: 235

$138.3M

Industry Research Awards

2020: $115.1M
2019: $118.4M
2018: $110.2M

10

New Business Startups

2020: 16
2019: 11
2018: 7

182

License/Option Agreements

2020: 166
2019: 114
2018: 112

1,382

Industry Award Count

2020: 1,382
2019: 1,226
2018: 1,279

COMMERCIALIZATION EDUCATION

$40M+

Follow-on Funding

awarded to date for teams that have gone through an FFMI education program

32

Commercialization Education Programs

serving biomedical innovators across the University of Michigan, and across the state, region, and nation

4,000+

Participants

enrolled in Commercialization Education programs to date

33

Institutions

across the state, region, and nation (outside of the University of Michigan) that have participated in FFMI fastPACE

FUNDING & MENTORSHIP

$3M

Frankel Innovation Initiative Funding

awarded in second round

$2M

Annual MTRAC for Life Sciences Innovation Hub Funding

statewide

$82.1M

Follow-On Funding for MTRAC

since 2014 launch

30

MTRAC Startups

since 2014 launch

MICHIGAN BIOMEDICAL VENTURE FUND

13

Michigan Biomedical Venture Fund

portfolio companies since launch

12 out of 13

Companies

have received follow-on funding/co-investments

21:1

$21 of Follow-On Funding

for every $1 of Michigan Biomedical Venture Fund

$56.84M

Follow-On Funding

for all companies combined

QUESTIONS?

Have questions about biomedical innovation at the University of Michigan? Contact Fast Forward Medical Innovation at ffmioffice@umich.edu.

X